Philip Nickson
Chief Business & Legal OfficerMr. Philip Nickson, Ph.D., J.D., also known as Phil, served as General Counsel at Monte Rosa Therapeutics, Inc. since March 2022 until May 30, 2024 and serves as its Chief Business and Legal Officer since May 30, 2024 and served as its Head of Legal Operations until 2022. Mr. Nickson joined the Monte Rosa Therapeutics, Inc. in 2020. He is responsible for all aspects of the company’s legal and intellectual property functions. He joined Monte Rosa from Momenta Pharmaceuticals, acquired by Johnson and Johnson in 2020, where he was Vice President, Intellectual Property. He spent years with Momenta focused on engineering legal and IP solutions to support the company’s business interests and ultimately playing a pivotal role in the company’s acquisition. He spent his early legal career with Fish and Richardson in Boston representing a diverse range of clients with varying technologies. He holds a JD from Suffolk University and a PhD from University of Manchester.
Positions
- Company NameMonte Rosa Therapeutics, Inc.Stock CodeGLUEPositionChief Business & Legal OfficerColleagues
- MWMarkus WarmuthPresident, CEO & Director
- ANAndrew Newman SchiffIndependent Chairman of the Board
- FJFilip JankuChief Medical Officer
- MBMatthew BowenCorporate Controller & Principal Accounting Officer
- JCJennifer ChampouxChief Operating Officer
- KLKimberly Lynn BlackwellIndependent Director
- CEChristine E. SiuIndependent Director
- JSJan SkvarkaIndependent Director
